Alzamend Neuro, Inc. (ALZN) — Analyst outlook / Analyst consensus target is. Based on 2 analyst ratings, the consensus is bullish — 2 Buy.
Analysts estimate Earnings Per Share (EPS) of $-11.88 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2025: actual $-11.32 vs est $-11.88 (beat +4.7%). Analyst accuracy: 95%.
ALZN Analyst Ratings
Buy
Based on 2 analysts giving stock ratings to Alzamend Neuro, Inc. in the past 3 months
EPS Estimates — ALZN
95%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2025
Actual –$11.32
vs Est –$11.88
▲ 4.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — ALZN
Revenue Trend
Analysts expect stable revenue going forward.
